29
Participants
Start Date
December 11, 2015
Primary Completion Date
July 16, 2019
Study Completion Date
July 16, 2019
Ramucirumab
Administered IV
Columbia University Medical Center, New York
Childrens Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Mark O Harfield-Warren Grant Magnuson Clinical Center, Bethesda
Children's Healthcare of Atlanta at Scottish Rite, Atlanta
Childrens Hospital of Alabama, Birmingham
St Jude Childrens Research Hospital, Memphis
Riley Hospital for Children, Indianapolis
University of Michigan Health Systems, Ann Arbor
Medical College of Wisconsin, Milwaukee
University of Minnesota Hospital, Minneapolis
Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Washington University Medical School, St Louis
Texas Childrens Hospital, Houston
Children's Oncology Group, Monrovia
Childrens Hospital of Orange County, Orange
University of California, San Francisco, San Francisco
Oregon Health and Science University, Portland
Seattle Children's Hospital Research Foundation, Seattle
Children's National Medical Center, Washington D.C.
Children's Hospital Medical Center, Cincinnati
Children's Oncology Group
NETWORK
Eli Lilly and Company
INDUSTRY